好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Eligibility for Rt-PA within a Population: The Effect of the ECASS 3 Trial
Cerebrovascular Disease and Interventional Neurology
(-)
003
Authors/Disclosures
Dawn O. Kleindorfer, MD, FAAN (University of Michigan Department of Neurology) Dr. Kleindorfer has nothing to disclose.
Pawani Sachar, MD (PMG Neurology) Dr. Sachar has nothing to disclose.
No disclosure on file
Kathleen Alwell No disclosure on file
No disclosure on file
Daniel Woo, MD, FAAN (University at Buffalo) The institution of Dr. Woo has received research support from NIH.
Matthew L. Flaherty, MD Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Joseph P. Broderick, MD, FAAN (University of Cincinnati) Dr. Broderick has received publishing royalties from a publication relating to health care.
Brett M. Kissela, MD, MS, FAAN (University of Cincinnati Hospital) The institution of Dr. Kissela has received research support from NIH/NINDS.